Weekly Updates & Resources from CHUG
BAMLANIVIMAB USED AS EARLY STRATEGY FOR ILLINOIS CRITICAL CARE FACILITIES
On, November 6th, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of bamlanivimab for high-risk COVID-19 patients.
The new strategy requires weekly allocations to be released with prioritization of Safety Net Hospitals, Critical Access Hospitals, and consideration for ICU patients.
During the week of November 23rd, 2020, 2,930 vials were allocated
During the week of November 30th, 2020, the state of Illinois was allocated 3,160 vials of Eli Lilly’s bamlanivimab and 2,280 vials of Regeneron’s casiriv for antibody treatment
CHUG UPDATES: Even if you have an emergency family evacuation plan, you may not have thought through what you would do with your pets during an unplanned event that requires you to leave your home. Here’s what CHUG recommends to keep your pets safe.
Additional Resource Library:
As Hospitals Fill with COVID Patients, Medical Reinforcements are Hard to Find
At Tiny Rural Hospitals, Weary Doctors Treat Friends, Family
Study: Integrating Palliative Care Earlier in Care Trajectory Benefits COVID-19 Patients
'Anti-Antibiotic' Allows for Use of Antibiotics Without Driving Resistance
Long-Term-Care Residents and Health Workers Should Get Vaccine First, C.D.C. Panel Says